AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
Omnigence research spots a North American fertilizer efficiency edge
AGP
Omnigence Asset Management published new research on Nov. 4 comparing fertilizer efficiency across grain systems in the U.S., Canada, Brazil and China.
Cathay Financial Holdings pushes risk management to unlock climate capital
AGP
At Climate Week NYC, Cathay Financial Holdings said climate finance needs better risk assessment, stronger public-private partnerships and more reliable data to turn pledges into bankable projects.
Schneider Electric India posts double-digit Q2 growth as parent lifts full-year outlook
AGP
Schneider Electric said its India business delivered double-digit Q2 2026 growth in energy management and industrial automation as the global parent raised its full-year earnings outlook.
IDG Capital tops multiple 2025 China VC rankings
AGP
IDG Capital was ranked No. 1 by Zero2IPO, Jiemian News and ChinaVenture in 2025, while AVCJ named a related secondary deal “Deal of the Year – Secondary.” The results highlight the firm’s exit performance and growing strength in secondary…
RBI Asia Trailblazer Awards open entries with new tech implementation categories
AGP
Retail Banker International has opened entries for the 18th annual RBI Asia Trailblazer Awards 2027, adding 15 bank and technology implementation categories that broaden recognition across digital banks, specialist lenders and banking…
APERC official says AI can help Asia-Pacific energy systems use less power
AGP
An APERC senior vice chair says artificial intelligence, grid upgrades and green technologies are helping reshape the Asia-Pacific energy transition as demand rises and energy security pressures grow.
Kenno names Chris Hunt as CIO as Vietnam market upgrade opens new investor demand
AGP
Kenno has appointed former Macquarie Asia research head Chris Hunt as chief investment officer, effective Oct. 14, 2026, as the Singapore-based Vietnam specialist positions for growth.
Lunsumio market seen growing on rising blood cancer cases
AGP
The Business Research Company says the global market for Lunsumio, a bispecific antibody therapy for relapsed or refractory follicular lymphoma, is set to expand through 2035 as cancer treatment shifts toward personalized immuno-oncology.
Atrial fibrillation market to hit $27.88 billion by 2030
AGP
The atrial fibrillation market is expected to grow from $15.1 billion in 2025 to $27.88 billion by 2030, according to The Business Research Company.
China gel pen assembly machine makers face a higher bar in 2026
AGP
Suzhou Paifeite Automation Technology is leading a 2026 review of Chinese gel pen assembly machine manufacturers as export demand, automation and medical-device requirements push buyers to evaluate capacity, certification and flexibility.
Five China custom chemical equipment makers profiled for 2026 projects
AGP
A 2026 industry review spotlights five China-based manufacturers of custom chemical equipment, with a focus on reactors, heat exchangers, separation systems and integrated process packages.
Alyona Lebedeva says Central Asia must turn transit routes into production links
AGP
At a Tashkent conference on Oct. 20-21, Alyona Lebedeva argued that Central Asia should use new transport corridors to grow manufacturing, not just transit.
Five China law firms flagged for high-net-worth divorce work in 2026
AGP
A 2026 market review identified five China-based firms for high-net-worth divorce matters as cross-border assets, company equity and multi-jurisdiction disputes grow more complex.
China enclosure makers gain ground as demand shifts to customized, certified designs
AGP
A 2026 industry overview spotlights 10 Chinese manufacturers of customized electrical enclosures, led by Dalian Yinlu Electrical Control Equipment Manufacturer in Dalian.
Drug repurposing market seen reaching $43.21 billion by 2031
AGP
Mordor Intelligence says the global drug repurposing market will rise from $37.46 billion in 2026 to $43.21 billion by 2031 as AI tools, regulatory pathways and rare-disease research expand the use of existing medicines.
Lumizyme market seen expanding on rare disease demand
AGP
The Business Research Company says the global Lumizyme market should keep growing through 2035, driven by more rare disease diagnoses, rising healthcare spending and wider use of home infusion care.
SIEF launches China-Arab investment report and World Bank partnership at Investopia
AGP
Sino-International Entrepreneurs Federation unveiled its 2026 China-Arab Business & Investment Report in Abu Dhabi on Oct. 7 and announced a new strategic partnership with the World Bank. The moves aim to deepen China-Arab commercial ties and…
Autoimmune treatment market seen reaching $16.53 billion by 2030
AGP
The Business Research Company says the autoimmune treatment market will rise from $8.63 billion in 2025 to $9.84 billion in 2026, then climb to $16.53 billion by 2030. The report points to higher diagnosis rates, more biologics, and growing…
Sage Healthcare adds directors in the US and Europe
AGP
Sage Healthcare has appointed Joe Smith in the United States and Dr Rino Coladangelo in the United Kingdom as directors, expanding its transatlantic dealmaking bench.
Autologous cell therapy market seen reaching $27.31 billion by 2030
AGP
The Business Research Company says the autologous cell therapy market will grow from $12.14 billion in 2025 to $27.31 billion by 2030, driven by chronic disease demand, oncology use and faster manufacturing.
Sign up for:
Asia Pacific Finance Daily
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.